# Patients' Attitudes Toward and Experiences With Buprenorphine Treatment

> **NCT05121428** · — · SUSPENDED · sponsor: **Cambridge Health Alliance** · enrollment: 817 (actual)

## Conditions studied

- Opioid-use Disorder
- Acceptability of Health Care
- Opioid-Related Disorders

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05121428
- **Lead sponsor:** Cambridge Health Alliance
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** SUSPENDED
- **Start date:** 2021-11-20
- **Primary completion:** 2025-03-20
- **Final completion:** 2027-03-20
- **Target enrollment:** 817 (ACTUAL)
- **Why stopped:** Study completed Phase 1 before funding ended.
- **Last updated:** 2025-07-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05121428

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05121428, "Patients' Attitudes Toward and Experiences With Buprenorphine Treatment". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05121428. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*